Produktname:lithium(1+) ion 2-(pyridin-4-yl)spiro[3.3]heptane-2-carboxylate
IUPAC Name:lithium(1+) 2-(pyridin-4-yl)spiro[3.3]heptane-2-carboxylate
- CAS：2137536-42-4
- Molekulare Formel：C13H14LiNO2
- Reinheit：95%+
- Katalognummer：CM470230
- Molekulargewicht：223.2
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:2137536-42-4
- Molekulare Formel:C13H14LiNO2
- Schmelzpunkt:-
- SMILES-Code:[Li+].[O-]C(=O)C1(CC2(CCC2)C1)C1=CC=NC=C1
- Dichte:
- Katalognummer:CM470230
- Molekulargewicht:223.2
- Siedepunkt:
- Mdl-Nr.:MFCD31457182
- Lagerung:
Category Infos
- Pyridines
- Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
- Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
- Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
- Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.
- Cyclobutanes
- The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.
Suche 
+86 21 5895 0110 
